Literature DB >> 3812426

Exposure opportunity in epidemiologic studies.

J J Schlesselman, B V Stadel.   

Abstract

We have shown that consideration of exposure opportunity is crucial to planning epidemiologic investigations because it focuses studies on questions of relevance, it helps to identify links to variables that can distort the assessment of an exposure's effect, and the cost of investigation can be reduced by the use of appropriate eligibility criteria. The reasons given by Poole for ignoring exposure opportunity are based on misleading claims of increased precision, disregard for probable confounding by factors related to exposure opportunity, and failure to consider realistically the cost of obtaining data on persons whose experience is irrelevant to the issues under investigation.

Entities:  

Keywords:  Cardiovascular Effects; Contraception; Contraceptive Agents, Female; Data Analysis; Data Collection; Diseases; Double-blind Studies; Epidemiologic Methods; Family Planning; Follow-up Studies; Heart Diseases; Infertility; Myocardial Infarction; Oral Contraceptives; Research Methodology; Studies; Study Design; Urogenital Effects

Mesh:

Substances:

Year:  1987        PMID: 3812426     DOI: 10.1093/oxfordjournals.aje.a114517

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  3 in total

1.  Invited commentary: positivity in practice.

Authors:  Daniel Westreich; Stephen R Cole
Journal:  Am J Epidemiol       Date:  2010-02-05       Impact factor: 4.897

Review 2.  Who and what is a "population"? Historical debates, current controversies, and implications for understanding "population health" and rectifying health inequities.

Authors:  Nancy Krieger
Journal:  Milbank Q       Date:  2012-12       Impact factor: 4.911

3.  The association between car accident fatalities and children's fears: A study in seven EU countries.

Authors:  Viviane Kovess-Masfety; David Sowa; Katherine Keyes; Mathilde Husky; Christophe Fermanian; Adina Bitfoi; Mauro Giovanni Carta; Ceren Koç; Dietmar Goelitz; Sigita Lesinskiene; Zlatka Mihova; Roy Otten; Ondine Pez
Journal:  PLoS One       Date:  2017-08-03       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.